Ethical issues related to the use of placebo in clinical trials

Hong Kong Medical Journal

Volumn 9, Issue 3, 2003, Pages 192-198

  Lau, J T F ^a   Mao, J ^a   Woo, J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Clinical trials; Ethics; Placebos

Indexed keywords

PLACEBO;

ADVERSE DRUG REACTION; ATTITUDE; CLINICAL TRIAL; HONG KONG; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; REVIEW; RISK BENEFIT ANALYSIS; TRAINING;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

CLINICAL TRIALS; ETHICS, MEDICAL; HELSINKI DECLARATION; HUMANS; PLACEBOS;

EID: 0038690598     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Emanuel EJ, Miller FG. The ethics of placebo-controlled trials - a middle ground. N Engl J Med 2001;345:915-9.
2. World Medical Association. Declaration of Helsinki V: ethical principles for medical research involving human subjects. 52nd World Medical Assembly, Edinburgh, Scotland, October 2000.
3. World Medical Association. Note of clarification on paragraph 29 of the WMA Declaration of Helsinki. October 2001.
4. Temple R. Government viewpoint of clinical trials. Drug Information J 1982;16:10-7.
5. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5.
6. Huston P, Peterson R. Withholding proven treatment in clinical research. N Engl J Med 2001;345:912-4.
7. Rothman KJ. Declaration of Helsinki should be strengthened. BMJ 2000;321:442-5.
8. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-8.
9. Forster HP, Emanuel E, Grady C. The 2000 revision of the Declaration of Helsinki: a step forward or more confusion? Lancet 2001;358: 1449-53.
10. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994; 271:1609-14.
11. Simon R. Are placebo-controlled clinical trials ethical or needed when alternative treatment exists? Ann Intern Med 2000;133:474-5.
12. Reynolds T. The ethics of placebo-controlled trials. Ann Intern Med 2000;133:491.
13. Vastag B. Helsinki discord? A controversial declaration. JAMA 2000; 284:2983-5.
14. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatment. Part 1: ethical and scientific issues. Ann Intern Med 2000;133:455-63.
15. ICH Steering Committee. ICH harmonized tripartite guideline: Choice of control group and related issues in clinical trials. July 2000.
16. The European Agency for the Evaluation of Medicinal Products, Pre-authorization evaluation of medicines for human use. EMEA/CPMP position statement on the use of placebo in clinical trials with regard to the revised Declaration of Helsinki. EMEA 2001;17424/01.
17. Orentlicher D. Placebo-controlled trials of new drugs: ethical considerations. Diabetes Care 2001;24:771-2.
18. Simon R. Are placebo-controlled trials ethical or needed when alternative treatment exists? Ann Intern Med 2000;133:474-5.
19. Vickers AJ, de Craen AJ. Why use placebos in clinical trials? A narrative review of the methodological literature. J Clin Epidemiol 2000;53:157-61.
20. Roberts LW, Lauriello J, Geppert C, Keith SJ. Placebos and paradoxes in psychiatric research: an ethics perspective. Biol Psychiatry 2001;49:887-93.
21. Benson H, Friedman R. Harnessing the power of the placebo effect and renaming it "remembered wellness". Annu Rev Med 1996;47: 193-9.
22. Leber P. The placebo control in clinical trials (a view from the FDA). Psychopharmacol Bull 1986;22:30-2.
23. Weihrauch TR, Gauler TC. Placebo - efficacy and adverse effects in controlled clinical trials. Arzneimittelforschung 1999;49:385-93.
24. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 2000;57:311-7.
25. Storosum JG, van Zwieten BJ, van den Brink W, Gersons BP, Broekmans AW. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 2001;158:1271-5.
26. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
27. Al-Khatib SM, Califf RM, Hasselblad V, Alexander JH, McCrory DC, Sugarman J. Medicine. Placebo-controls in short-term clinical trials of hypertension. Science 2001;292:2013-5.
28. Bell DSH. Ethics in diabetic clinical trials. Diabetes Care 2001;24:606.
29. Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. N Eng J Med 2001;345:139-42.